NLRP3 and diabetic cardiomyopathy: A study reported that the NLRP3 inflammasome contributed to the development of diabetic cardiomyopathy via ROS‐induced caspase‐1 and IL‐1β activation, which are the effectors of the NLRP3 inflammasome.